Skip to content

Effect of metformine on non diabetic obese pregnant women

Investigating the effect of metformine on the state of oxidative stress and antioxidants in non diabetic obese pregnant mothers: A randomized clinical trial study

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250111064345N1
Enrollment
50
Registered
2025-11-16
Start date
2025-11-22
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational diabetes in pregnant women with obesity. Other and unspecified metabolic disorders

Interventions

Intervention 1: Intervention group: Participants in the intervention group, after the initial measurement of inflammatory and oxidative stress factors, will start treatment with metformin. They will b

Sponsors

Yasouj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: gestational age between 12-16 weeks single pregnancy Body mass index over 30

Exclusion criteria

Exclusion criteria: Abnormality in anomaly scan Allergy to metformine Diagnosis of gestational diabetes

Design outcomes

Primary

MeasureTime frame
Total Antioxidant Capacity (TAC) of Plasma. Timepoint: Before and after intervention. Method of measurement: Spectrophotometer.;Serum concentrations of nitrite metabolites. Timepoint: Before and after intervention. Method of measurement: Spectrophotometer.;Protein Sulfhydryl. Timepoint: Before and after intervention. Method of measurement: Spectrophotometer.;Protein carbonyl. Timepoint: Before and after intervention. Method of measurement: Spectrophotometer.;Malondialdehyde (MDA) concentration. Timepoint: Before and after intervention. Method of measurement: Spectrophotometer.;Superoxide Dismutase (SOD) Activity. Timepoint: Before and after intervention. Method of measurement: Spectrophotometer.;Serum concentrations of nitrate metabolites. Timepoint: Before and after intervention. Method of measurement: Spectrophotometer.

Secondary

MeasureTime frame
Body mas index. Timepoint: Before and after intervention. Method of measurement: Scales and meters.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFateme Esameilpour

Yasouj University of Medical Sciences

Esmparastoo@Gmail.Com+98 917 987 5430

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026